Login to Your Account

Other News To Note

Monday, December 27, 2010
Oramed Pharmaceuticals Inc., of Jerusalem, was awarded a NIS2.9 million (US$807,000) grant from the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of Israel. The funding will support development of Oramed's oral insulin and oral GLP-1 analogue for diabetes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription